Rabbit Polyclonal TOX1 antibody. Suitable for IP, ELISA, Dot, WB, Neut and reacts with Bordetella pertussis samples. Cited in 2 publications.
pH: 6 - 8.5
Preservative: 0.09% Sodium azide
IP | ELISA | Dot | WB | Neut | |
---|---|---|---|---|---|
Bordetella pertussis | Expected | Tested | Expected | Tested | Expected |
Species | Dilution info | Notes |
---|---|---|
Species Bordetella pertussis | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Bordetella pertussis | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Bordetella pertussis | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Bordetella pertussis | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Bordetella pertussis | Dilution info Use at an assay dependent concentration. | Notes - |
Select an associated product type
S1 is an NAD-dependent ADP-ribosyltransferase, which plays a crucial role in the pathogenesis of B.pertussis causing disruption of normal host cellular regulation. It catalyzes the ADP-ribosylation of a cysteine in the alpha subunit of host heterotrimeric G proteins. In the absence of G proteins it also catalyzes the cleavage of NAD(+) into ADP-ribose and nicotinamide. It irreversibly uncouples the G-alpha GTP-binding proteins from their membrane receptors.
ptxB, ptxC, ptxE, ptxD, ptxA
BP3783, ptxA, Pertussis toxin subunit 1, PTX S1, Islet-activating protein S1, NAD-dependent ADP-ribosyltransferase, IAP S1
Rabbit Polyclonal TOX1 antibody. Suitable for IP, ELISA, Dot, WB, Neut and reacts with Bordetella pertussis samples. Cited in 2 publications.
pH: 6 - 8.5
Preservative: 0.09% Sodium azide
Bordetella pertussis toxin often called pertussis toxin or PTX functions mechanically as an exotoxin produced by Bordetella pertussis. This toxin has a molecular mass of around 105 kDa and comes from the bacterium responsible for whooping cough. It expresses itself in various host cells after the bacterium releases it into the respiratory tract during infection. The pertussis toxin consists of five subunits S1 through S5 which work together to impair host cellular functions by catalyzing the ADP-ribosylation of G-proteins.
Pertussis toxin disrupts host immune responses and cellular signaling pathways. It is an important component of the Anti-CENPF antibody ab5 toxin family where one A subunit and five B subunits form a complex to enter cells. The toxin binds to cell surface glycoproteins facilitating its uptake and subsequent inhibition of G-protein-coupled receptor (GPCR) signaling. This action interferes with a variety of intracellular processes ultimately leading to altered immune regulation and enhanced bacterial colonization.
Pertussis toxin plays a significant role in the intracellular signaling pathways especially impacting the GPCR pathways. The toxin's catalytic subunit modifies the alpha subunit of inhibitory G-proteins (Gi) which prevents normal signal transduction from the GPCRs. This dysregulation impairs processes such as cyclic AMP (cAMP) regulation and immune response modulation. In the GPCR pathway B. pertussis toxin shows close functional relationships with other G-protein coupled components.
Pertussis toxin significantly contributes to the development of whooping cough a respiratory disease that can lead to severe coughing fits. This toxin affects various host immune proteins like chemokine receptors complicating immune response against the Bordetella pertussis bacterium. Additionally its action on the GPCR signaling pathway implicates it in other related respiratory conditions making pertussis toxin a pivotal target for therapeutic interventions and vaccine development against whooping cough.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
The toxin consists of five subunits as indicated by S1 to S5.
All lanes: Western blot - Anti-Bordetella pertussis toxin/ptxD antibody (ab188414) at 1/2000 dilution
Lane 1: Culture medium of Bordetella pertussis
Lane 2: Purified Bordetella pertussis toxin/ptxD at 0.01 µg
ELISA analysis of Bordetella pertussis toxin/ptxD, using ab188414. Plate was coated with 100 μg of pertussis toxin per well and 100 μl of ab188414 at the indicated dilution was added to each well and incubated. After washing, goat anti-rabbit-IgG conjugated with HRP was added as a secondary antibody. Color was developed with TMB as substrate.
ELISA analysis of Bordetella pertussis toxin/ptxD, using ab188414 at 1/12500 dilution. Plate was coated with indicated amounts of pertussis toxin per well and 100 μl of ab188414 was added to each well and incubated. After washing, goat anti-rabbit-IgG conjugated with HRP was added as a secondary antibody. Color was developed with TMB as substrate. Dynamic range was 100 pg to 10 ng under these conditions.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com